In Vitro Evaluation of Antiproliferative Activity of CCRF-CEM Supernatant on Lymphoid and Nonlymphoid Leukemic Cells

  • R. Perricone
  • M. Tolomeo
  • R. Petruzzella
  • C. Tomaselli
  • A. Costa
  • E. Caravello
  • V. Abbadessa
  • A. Cajozzo
Conference paper


Several glycoproteins are able to inhibit cell proliferation in vitro and in vivo [1–4]. Some of these have been purified to homogeneity, cloned, sequenced (interferon, IFN-γ [5–7] and tumor necrosis factor, TNF [8–12], and utilized in clinical trials. T-lymphoblastic leukemic cells and actived T cells are the cellular lines mostly involved in the production of glycoproteins with antiproliferative properties. Recently, particular attention has been focused on two glycoproteins isolated from T-lymphoblastic cell line MT-1 and CCRF- GEM supernatants:CIL (colony inhibiting lymphokine) [13, 14] and TLSL (T-leukemia derived suppressor lymphokine) [15]. CIL and TLSL have the same molecular weight and the same chemical-physical properties. They inhibit clonogenic activity and DNA synthesis of normal hemopoietic precursor cells as well as of a variety of malignant hemopoietic cells. However, not all leukemic cells are sensitive, showing heterogeneity of response. TLSL and CIL are cytostatic, and treated target cells accumulate either in G1 or S phase of the cell cycle. The cellular sensitivity to the inhibitory action of CIL has been correlated with expression on the cell membrane of HLA-Dr antigen. It particulary inhibits proliferation of human Epstein-Barr virus (EBV) transformed lymphoblastoid lines (HLA-Dr+) but is much less inhibitory on myeloid leukemic lines (HL-60, K-562). TLSL is also active on cell lines not expressing HLA-Dr antigen.


Cell Growth Inhibition Human Tumor Necrosis Factor Hemopoietic Progenitor Recombinant Human Tumor Necrosis Factor Human Tumor Necrosis Factor Alpha 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kasahura S, Taguchi M, Murachi T, Uchino H, Hanaoka M (1983) A new mediator (suppressor cell induction factor) activating T-cell mediated suppression:characterization of suppressor cells, kinetics of their generation, and mechanism of their action. J Immunol 131:2307Google Scholar
  2. 2.
    Green WC, Fleisher TA, Waldman TA (1981) Soluble suppressor supernatants elaborated by concanavalin A-activated human mononuclear cells. Characterization of a soluble suppressor of T cell proliferation. J Immunol 126:1185Google Scholar
  3. 3.
    Kawano M, Iwato K, Kuramoto A (1985) Identification and characterization of a B cell growth inhibitory factor ( BIF) on BCGF-dependent B cell proliferation. J Immunol 134:375PubMedGoogle Scholar
  4. 4.
    Lau CY, Wang EY, Li D, Budz-Tymkewycz S, Visonti V, Ishaque A (1985) Mechanism of action of a suppressor activating factor (SAF) produced by a human T-cell line J Immunol 134:3155Google Scholar
  5. 5.
    Yip YK, Pang RHL, Urban C, Vilcek J (1981) Partial purification and characterization of human gamma (immune) interferon. Proc Natl Acad Sci USA 78:1061CrossRefGoogle Scholar
  6. 6.
    Weinberg JB, Misukonis MA, Hobbs MM, Borowitz MJ (1986) Cooperative effects of gamma interferon and 1 alpha, 25-dihydroxyvitamin D3 in inducing differentiation of human promyelocytic leukemia (HL-60) cells. Exp Hematol 14:138PubMedGoogle Scholar
  7. 7.
    Ball ED, Howell AL, Shen L (1986) Gamma interferon and 1, 25 dihydroxyvitamin D3 cooperate in the induction of monocytoid differentiation but not in the functional activation of the HL-60 promyelocytic leukemia cells. Exp Hematol 14:998PubMedGoogle Scholar
  8. 8.
    Pennica D, Nedwin GE, Hayflick JS, Seeburg PH, Derynck R, Palladino MA, Kohr WJ, Aggarwal BB, Goeddler DV (1984) Human tumor necrosis factor:precursor structure, expression and homology to lymphotoxin. Nature 312:724PubMedCrossRefGoogle Scholar
  9. 9.
    Ostensen ME, Thiele DL, Lipsky PE (1987) Tumor necrosis factor-alpha enhanced cytolytic activity of human natural killer cells. J Immunol 138:4185PubMedGoogle Scholar
  10. 10.
    Weinberg JB, Larrick JW (1987) Receptor-mediated monocytoid differentiation of human promyelocytic cells by tumor necrosis factor:synergistic actions with gamma interferon and 1, 25 dihydroxyvitamin D3. Blood 70:994Google Scholar
  11. 11.
    Trinchieri G, Kobayashi M, Rosen M, Loudon R, Murphy M, Perussi B (1986) Tumor necrosis factor and lymphotoxin induce differentiation of human myeloid cell lines in synergy with immune interferon. J Exp Med 164:1206PubMedCrossRefGoogle Scholar
  12. 12.
    Rao KMK, Misukonis MA, Cohen HJ, Weinberg JB (1988) Cooperative effects of tumor necrosis factor and gamma interferon on chemotactic peptide receptor expression and stimulus-induced actin polymerization in HL-60 cells. Blood 71:1062PubMedGoogle Scholar
  13. 13.
    Trucco M, Rovera G, Ferrero D (1984) A novel human limphokine that inhibits hemopoietic progenitor cell proliferation. Nature 309:166.PubMedCrossRefGoogle Scholar
  14. 14.
    Migliaccio AR, Migliaccio G, Ferrero D, Russo D, Peschle C (1986) Colony-inhibiting factor (CIL) from human T-cell lines suppresses proliferation of adult but non embryonic fetal hemopoietic progenitors. In:R Baserga, P Foa, D Metcalf, EE Polli (eds.) Serono symposia publication, vol 34. Raven, New York, p 195Google Scholar
  15. 15.
    Santoli D, Tweardy DJ, Ferrero D, Kreider BL, Rovera G (1986) A suppressor lymphokine produced by human T-leukemia cell lines. J Exp Med 167:18CrossRefGoogle Scholar

Copyright information

© Springer-Verlag, Berlin Heidelberg 1990

Authors and Affiliations

  • R. Perricone
  • M. Tolomeo
  • R. Petruzzella
  • C. Tomaselli
  • A. Costa
  • E. Caravello
  • V. Abbadessa
  • A. Cajozzo

There are no affiliations available

Personalised recommendations